Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 May;32(5):631–635. doi: 10.1128/aac.32.5.631

Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.

K J Klamerus 1, K A Rodvold 1, N A Silverman 1, S Levitsky 1
PMCID: PMC172243  PMID: 3395099

Abstract

The effect of cardiopulmonary bypass (CPB) on the disposition of vancomycin (15 mg/kg) and of netilmicin (3 mg/kg) was studied in 10 adults. The concentration-time profile of the drug in serum and renal clearance were characterized pre-CPB, during CPB, and post-CPB. Vancomycin and netilmicin exhibited initial decreases in mean concentrations in serum of 4.0 mg/liter (16.8%) and 2.2 mg/liter (29.1%), respectively, upon initiation of CPB. Netilmicin concentrations in serum rebounded to a mean of 0.6 mg/liter (15.4%) within 90 min on CPB and then continuously decreased. Vancomycin concentrations in serum demonstrated a rebound increase of 2.3 mg/liter (23.5%) at the end of CPB when the aorta was unclamped. Mean renal clearance throughout CPB was decreased for vancomycin (58.4 to 43.4 ml/min per m2) and netilmicin (53.4 to 31.5 ml/min per m2). The rebound in vancomycin concentration in serum strongly correlated with the length of time between unclamping the aorta and coming off CPB (r = 0.94), as well as with the increase in temperature upon rewarming (r = 0.92).

Full text

PDF
634

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akl B. F., Richardson G. Serum cefazolin levels during cardiopulmonary bypass. Ann Thorac Surg. 1980 Feb;29(2):109–112. doi: 10.1016/s0003-4975(10)61646-3. [DOI] [PubMed] [Google Scholar]
  2. Austin T. W., Leake J., Coles J. C., Goldbach M. M. Vancomycin blood levels during cardiac bypass surgery. Can J Surg. 1981 Jul;24(4):423–425. [PubMed] [Google Scholar]
  3. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
  4. Craig W. A., Gudmundsson S., Reich R. M. Netilmicin sulfate: a comparative evaluation of antimicrobial activity, pharmacokinetics, adverse reactions and clinical efficacy. Pharmacotherapy. 1983 Nov-Dec;3(6):305–315. doi: 10.1002/j.1875-9114.1983.tb03283.x. [DOI] [PubMed] [Google Scholar]
  5. Culliford A. T., Cunningham J. N., Jr, Zeff R. H., Isom O. W., Teiko P., Spencer F. C. Sternal and costochondral infections following open-heart surgery. A review of 2,594 cases. J Thorac Cardiovasc Surg. 1976 Nov;72(5):714–726. [PubMed] [Google Scholar]
  6. Dasta J. F., Jacobi J., Wu L. S., Sokoloski T., Beckley P., Reilley T. E., Howie M. B. Loss of nitroglycerin to cardiopulmonary bypass apparatus. Crit Care Med. 1983 Jan;11(1):50–52. doi: 10.1097/00003246-198301000-00013. [DOI] [PubMed] [Google Scholar]
  7. Farber B. F., Karchmer A. W., Buckley M. J., Moellering R. C., Jr Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen. J Thorac Cardiovasc Surg. 1983 Jun;85(6):933–935. [PubMed] [Google Scholar]
  8. GERACI J. E., HEILMAN F. R., NICHOLS D. R., ROSS G. T., WELLMAN W. E. Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proc Staff Meet Mayo Clin. 1956 Oct 17;31(21):564–582. [PubMed] [Google Scholar]
  9. Ham J., Miller R. D., Benet L. Z., Matteo R. S., Roderick L. L. Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat. Anesthesiology. 1978 Nov;49(5):324–329. doi: 10.1097/00000542-197811000-00005. [DOI] [PubMed] [Google Scholar]
  10. Holley F. O., Ponganis K. V., Stanski D. R. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet. 1982 May-Jun;7(3):234–251. doi: 10.2165/00003088-198207030-00004. [DOI] [PubMed] [Google Scholar]
  11. Karchmer A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. doi: 10.1016/0002-9343(85)90374-2. [DOI] [PubMed] [Google Scholar]
  12. Kaye D. Prophylaxis for infective endocarditis: an update. Ann Intern Med. 1986 Mar;104(3):419–423. doi: 10.7326/0003-4819-104-3-419. [DOI] [PubMed] [Google Scholar]
  13. Koren G., Crean P., Klein J., Goresky G., Villamater J., MacLeod S. M. Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). Eur J Clin Pharmacol. 1984;27(1):51–56. doi: 10.1007/BF00553154. [DOI] [PubMed] [Google Scholar]
  14. Krogstad D. J., Moellering R. C., Jr, Greenblatt D. J. Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol. 1980 Apr;20(4 Pt 1):197–201. doi: 10.1002/j.1552-4604.1980.tb01696.x. [DOI] [PubMed] [Google Scholar]
  15. Matzke G. R., O'Connell M. B., Collins A. J., Keshaviah P. R. Disposition of vancomycin during hemofiltration. Clin Pharmacol Ther. 1986 Oct;40(4):425–430. doi: 10.1038/clpt.1986.201. [DOI] [PubMed] [Google Scholar]
  16. Miller K. W., Chan K. K., McCoy H. G., Fischer R. P., Lindsay W. G., Zaske D. E. Cephalothin kinetics: before, during, and after cardiopulmonary bypass surgery. Clin Pharmacol Ther. 1979 Jul;26(1):54–62. doi: 10.1002/cpt197926154. [DOI] [PubMed] [Google Scholar]
  17. Plachetka J. R., Salomon N. W., Copeland J. G. Plasma propranolol before, during, and after cardiopulmonary bypass. Clin Pharmacol Ther. 1981 Dec;30(6):745–751. doi: 10.1038/clpt.1981.233. [DOI] [PubMed] [Google Scholar]
  18. Riva R., Albani F., Baruzzi A., Galvani I., Perucca E. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients. Ther Drug Monit. 1982;4(4):341–352. doi: 10.1097/00007691-198212000-00003. [DOI] [PubMed] [Google Scholar]
  19. Rotschafer J. C., Crossley K., Zaske D. E., Mead K., Sawchuk R. J., Solem L. D. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother. 1982 Sep;22(3):391–394. doi: 10.1128/aac.22.3.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schwenzer K. S., Wang C. H., Anhalt J. P. Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther Drug Monit. 1983;5(3):341–345. doi: 10.1097/00007691-198309000-00017. [DOI] [PubMed] [Google Scholar]
  21. Slaughter L., Morris J. E., Starr A. Prosthetic valvular endocarditis. A 12-year review. Circulation. 1973 Jun;47(6):1319–1326. doi: 10.1161/01.cir.47.6.1319. [DOI] [PubMed] [Google Scholar]
  22. Stanbridge T. N., Greenall D. J. Netilmicin prophylaxis in open-heart surgery. J Antimicrob Chemother. 1984 Jan;13 (Suppl A):59–65. doi: 10.1093/jac/13.suppl_a.59. [DOI] [PubMed] [Google Scholar]
  23. Wenk M., Hemmann R., Follath F. Homogeneous enzyme immunoassay for netilmicin. Antimicrob Agents Chemother. 1982 Dec;22(6):954–957. doi: 10.1128/aac.22.6.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wittendorf R. W., Swagzdis J. E., Gifford R., Mico B. A. Protein binding of glycopeptide antibiotics with diverse physical-chemical properties in mouse, rat, and human serum. J Pharmacokinet Biopharm. 1987 Feb;15(1):5–13. doi: 10.1007/BF01062935. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES